Ardelyx Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.00

-0.87 (-17.86%)

As of Aug 9, 10:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +1,078.5% upside

Low Target $33.22

Average Target $47.14

High Target $55.45

Current Price $4.00

Current
$4.00

Target
$47.14

$33.22 $47.14 avg $55.45

Scenario Analysis

Bear Case

$33.22

730.5%

Low target

Base Case

$47.14

+1,078.5%

Avg target

Bull Case

$55.45

+1,286.3%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$8.40

-52.4% from high

52-Week Low

$4.71

+-15.1% from low

Target vs 52W High

$47.14

+461.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%